Journal of Immunology Research

Clinical Study

Platelets and Inflammatory Markers in Patients with Gastric Cancer

Table 2

The mean platelet count and their morphological parameters in patients suffering from gastric cancer—early gastric cancer, E (E1 before surgery, E2 after surgery), advanced cancer with metastasis to lymph nodes, A (A1 before surgery, A2 after surgery), and metastatic tumor, M (M1 before surgery, M2 after surgery) and in normal donors (C).


	PLT	MPV	LPLT
	X ± SD	X ± SD	X ± SD

Study group	248.53 ± 43.92	8.81 ± 0.64	6.1 ± 4.45
E1	E1 : C	E1 : C	E1 : C
	n.s.	n.s.	n.s.

Study group	528.43 ± 326.13	8.92 ± 0.82	14.1 ± 7.61
E2	E1 : E2	E1 : E2	E1 : E2
	P < 0.05 *	n.s.	n.s.

Study group	344.28 ± 266.40	9.48 ± 0.87	10.17 ± 8.56
A1	A1 : C	A1 : C	A1 : C
	n.s.	P < 0.05 *	P < 0.05 *

Study group	584.25 ± 237.54	9.64 ± 0.79	20.83 ± 12.43
A2	A1 : A2	A1:A2	A1 : A2
	P < 0.05 *	n.s.	P < 0.05 *

Study group	335.84 ± 154.08	9.04 ± 0.86	8.16 ± 3.47
M1	M1 : C	M1 : C	M1 : C
	P < 0.01 *	n.s.	P < 0.01 *

Study group	451.55 ± 210.74	9.23 ± 1.10	10.27 ± 5.69
M2	M1 : M2	M1 : M2	M1 : M2
	n.s.	n.s.	n.s.

Control group
C	247.78 ± 44.74	8.68 ± 0.64	5.34 ± 1.81

Statistically significant when P < 0.05.